Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: A systematic review of survival, mortality, and morbidity

Journal of Surgical Oncology

Volumn 104, Issue 6, 2011, Pages 692-698

  Gill, Richdeep S ^a   Al Adra, David P ^a   Nagendran, Jeevan ^a   Campbell, Sandy ^a   Shi, Xinzhe ^b   Haase, Erika ^a   Schiller, Daniel ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ROYAL ALEXANDRA HOSPITAL   (Canada)

Author keywords

cytoreductive surgery; gastric cancer; HIPEC; peritoneal carcinomatosis

Indexed keywords

CISPLATIN; MITOMYCIN;

ABDOMINAL ABSCESS; ANASTOMOSIS LEAKAGE; BLOOD TOXICITY; CARCINOMATOUS PERITONITIS; CHEMOSURGERY; CYTOREDUCTIVE SURGERY; EVALUATION AND FOLLOW UP; FISTULA; HEATED INTRAPERITONEAL CHEMOTHERAPY; HUMAN; LENGTH OF STAY; MORBIDITY; OPERATION DURATION; OVERALL SURVIVAL; PRIORITY JOURNAL; REVIEW; SEPSIS; STOMACH CANCER; SURGICAL MORTALITY; SURVIVAL TIME; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CARCINOMA; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; HUMANS; HYPERTHERMIA, INDUCED; PERITONEAL NEOPLASMS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 80053606329     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.22017     Document Type: Review

References (50)

1. Bertuccio P, Chatenoud L, Levi F, et al.: Recent patterns in gastric cancer: A global overview. Int J Cancer 2009; 125: 666-673.
2. Parkin DM, Bray F, Ferlay J, et al.: Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. (Pubitemid 40372904)
3. Ikeguchi M, Oka A, Tsujitani S, et al.: Relationship between area of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer. Anticancer Res 1994; 14: 2131-2134.
4. Sadeghi B, Arvieux C, Glehen O, et al.: Peritoneal carcinomatosis from non-gynecologic malignancies: Results: of the EVOCAPE 1 multicentric prospective study. Cancer 2000; 88: 358-363. (Pubitemid 30051820)
5. Pyrhonen S, Kuitunen T, Nyandoto P, et al.: Randomized comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 1995; 71: 587-591.
6. Murad AM, Santiago FF, Petroianu A, et al.: Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer 1993; 72: 37-41. (Pubitemid 23182046)
7. Scheithauer W, Kornek G, Zeh G, et al.: Palliative chemotherapy versus supportive care in patients with metastatic gastric cancer: A randomized trial. 68 Second International Conference on Biology, Prevention, Treatment of GI Malignancy Koln, Germany. 1995.
8. Hanazaki K, Mochizuki Y, Machida T, et al.: Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer. Hepatogastroenterology 1999; 46: 1238-1243. (Pubitemid 29224825)
9. Chu DZ, Lang NP, Thompson C, et al.: Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 1989; 63: 364-367. (Pubitemid 19035034)
10. Sugarbaker PH,: Peritonectomy procedures. Ann Surg 1995; 221: 29-42.
11. Sugarbaker PH, Jablonski KA,: Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995; 221: 124-132.
12. van Ruth S, Verwaal VJ, Zoetmulder FA,: Pharmacokinetics of intraperitoneal mitomycin C. Surg Oncol Clin N Am 2003; 12: 771-780. (Pubitemid 36920098)
13. Goldstein P, da Silva RG, Cabanas J, et al.: Management of peritoneal carcinomatosis from colon cancer, gastric cancer and appendix malignancy. Cancer Therapy 2005; 3: 299-320.
14. Preusser P, Wilke H, Achterrath W, et al.: Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer. J Clin Oncol 1989; 7: 1310-1317. (Pubitemid 19220134)
15. Mahteme H, Hansson J, Berglund A, et al.: Improved survival in patients with peritoneal metastases from colorectal cancer: A preliminary study. Br J Cancer 2004; 90: 403-407. (Pubitemid 38250636)
16. Glehen O, Kwiatkowski F, Sugarbaker PH, et al.: Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study. J Clin Oncol 2004; 22: 3284-3292. (Pubitemid 41103684)
17. Glehen O, Cotte E, Schreiber V, et al.: Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin. Br J Surg 2004; 91: 747-754. (Pubitemid 38746144)
18. Elias D, Lefevre JH, Chevalier J, et al.: Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 27: 681-685.
19. Glehen O, Gilly FN, Arvieux C, et al.: Peritoneal carcinomatosis from gastric cancer: A multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 2010; 17: 2370-2377.
20. Yang XJ, Li Y, Yonemura Y,: Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: Results from a Chinese center. J Surg Oncol 2010; 101: 457-464.
21. Shen P, Stewart JH IV, Levine EA,: Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: Non-colorectal indications. Curr Probl Cancer 2009; 33: 168-193.
22. Scaringi S, Kianmanesh R, Sabate JM, et al.: Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: A single western center experience. Eur J Surg Oncol 2008; 34: 1246-1252.
23. Roviello F, Marrelli D, Neri A, et al.: Treatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP): Postoperative outcome and risk factors for morbidity. World J Surg 2006; 30: 2033-2040. (Pubitemid 44655812)
24. Farma JM, Pingpank JF, Libutti SK, et al.: Limited survival in patients with carcinomatosis from foregut malignancies after cytoreduction and continuous hyperthermic peritoneal perfusion. J Gastrointest Surg 2005; 9: 1346-1353. (Pubitemid 41751130)
25. Yonemura Y, Kawamura T, Bandou E, et al.: Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg 2005; 92: 370-375. (Pubitemid 40445602)
26. Mussa A, Sandrucci S, Zanon C,: Intraoperative chemohyperthermia for advanced gastric cancer: A new procedure with closed abdomen and previously constructed anastomosis. Tumori 2001; 87: S18-S20. (Pubitemid 32928857)
27. Fujimura T, Yonemura Y, Nakagawara H, et al.: Subtotal peritonectomy with chemohyperthermic peritoneal perfusion for peritonitis carcinomatosa in gastrointestinal cancer. Oncol Rep 2000; 7: 809-814.
28. Beaujard AC, Glehen O, Caillot JL, et al.: Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 2000; 88: 2512-2519. (Pubitemid 30331957)
29. Sugarbaker PH, Chang D,: Results: of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999; 6: 727-731. (Pubitemid 30013648)
30. van de Vaart PJ, van der Vange N, Zoetmulder FA, et al.: Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: Pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines. Eur J Cancer 1998; 34: 148-154. (Pubitemid 28123393)
31. Elias D, Antoun S, Goharin A, et al.: Research on the best chemohyperthermia technique of treatment of peritoneal carcinomatosis after complete resection. Int J Surg Investig 2000; 1: 431-439.
32. Christophi C, Winkworth A, Muralihdaran V, et al.: The treatment of malignancy by hyperthermia. Surg Oncol 1998; 7: 83-90. (Pubitemid 29273924)
33. Jacquet P, Averbach A, Stuart OA, et al.: Hyperthermic intraperitoneal doxorubicin: Pharmacokinetics, metabolism, and tissue distribution in a rat model. Cancer Chemother Pharmacol 1998; 41: 147-154. (Pubitemid 28096269)
34. Storm FK,: Clinical hyperthermia and chemotherapy. Radiol Clin North Am 1989; 27: 621-627.
35. Van Cutsem E, Moiseyenko VM, Tjulandin S, et al.: Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 Study Group. J Clin Oncol 2006; 24: 4991-4997. (Pubitemid 46631401)
36. Koichi M, Fujii M, Kanamori N, et al.: Neoadjuvant chemotherapy with S-q and CDDP in advanced gastric cancer. J Cancer Res Clin Oncol 2006; 132: 781-785. (Pubitemid 44521453)
37. Yano M, Shiozaki H, Inoue M, et al.: Neoadjuvant chemotherapy followed by salvage surgery: Effect of survival of patients with primary noncurative gastric cancer. World J Surg 2002; 26: 1155-1159. (Pubitemid 36920275)
38. Inokuchi M, Yamashita T, Yamada H, et al.: Phase I/II study of S-1 combined with irinotecan for metastatic advanced gastric cancer. Br J Cancer 2006; 94: 1130-1135.
39. Yonemura Y, Endou Y, Shinbo M, et al.: Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery. J Surg Oncol 2009; 100: 311-316.
40. Elias D, Blot F, El Otmany A, et al.: Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001; 92: 71-76. (Pubitemid 32623042)
41. Pilati P, Mocellin S, Rossi CR, et al.: Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Ann Surg Oncol 2003; 10: 508-513. (Pubitemid 40486913)
42. Verwaal VJ, van Ruth S, De Bree E, et al.: Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003; 21: 3737-3743. (Pubitemid 46606227)
43. Verwaal VJ, Bruin S, Boot H, et al.: 8-year follow-up of randomized trial: Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 2008; 15: 2426-2432.
44. Cao C, Yan TD, Black D, et al.: A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 2009; 16: 2152-2165.
45. Chua TC, Yan TD, Saxena A, et al.: Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? A systematic review of morbidity and mortality. Ann Surg 2009; 249: 900-907.
46. Bijelic L, Yan TD, Sugarbaker PH,: Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. Ann Surg Oncol 2007; 14: 2281-2288. (Pubitemid 47174917)
47. Moradi BN III, Esquivel J,: Learning curve in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol 2009; 100: 293-296.
48. Smeenk RM, Verwall VJ, Zoetmulder FAN,: Learning curve of combined modality treatment in peritoneal surface disease. Br J Surg 2007; 94: 1408-1414. (Pubitemid 350144391)
49. Yan TD, Links M, Fransi S, et al.: Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancyâA journey to becoming a nationally funded peritonectomy center. Ann Surg Oncol 2007; 14: 2270-2280. (Pubitemid 47174916)
50. Kerkar SP, Kemp CD, Duffy A, et al.: The GYMSSA trial: A prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy alone. Trials 2009; 10: 121.